Fisker Inc. Stock Plummets Amidst Market FluctuationsFisker Inc. Stock Plummets Amidst Market Fluctuations

By: Alex Freidmen

U.S. stocks surged this morning after the release of the Producer Price Index data. The Dow climbed 0.11% to 39,084.58, the NASDAQ rose 0.30% to 16,226.13, and the S&P 500 also saw an increase, rising by 0.14% to 5,172.33.

Market Movements

Energy shares saw a 0.4% jump, while real estate shares fell by 0.6%.

Producer Price Index Data

The Producer Price Index for final demand in the U.S. rose by 0.6% month-over-month in February, surpassing the market’s expectation of a 0.3% increase.

Stocks on the Rise

Shares of Presto Automation Inc. (NASDAQ: PRST) surged 77%, Aptorum Group Limited (NASDAQ: APM) jumped 69%, and WiMi Hologram Cloud Inc. (NASDAQ: WIMI) saw a 35% increase.

Stocks on the Decline

Spruce Biosciences, Inc. (NASDAQ: SPRB) plummeted 78% after reporting financial results. Fisker Inc. (NYSE: FSR) dropped 50% amidst rumors of a possible bankruptcy filing, and Immuneering Corporation (NASDAQ: IMRX) fell 27% after announcing clinical trial results.

Commodities Update

Oil prices rose by 1.2% to $80.66, while gold fell by 0.5% to $2,169.10. Silver saw a 0.5% increase to $25.285, and copper dropped by 0.3% to $4.0485.

Global Market Overview

European shares showed mixed results, with various indices experiencing fluctuations. In the Eurozone, Spain’s annual inflation rate decreased to 2.8% in February, marking a six-month low compared to January’s 3.4%.

In the Asian markets, Japan’s Nikkei 225 gained 0.29%, Hong Kong’s Hang Seng Index fell 0.71%, China’s Shanghai Composite Index dropped 0.18%, and India’s S&P BSE Sensex saw a 0.5% increase.

Economic Indicators

Aside from the PPI data, U.S. retail sales rose by 0.6% month-over-month in February, jobless claims declined to 209,000, and various economic indicators underscored the dynamic nature of the current market landscape.

See also  Options Corner: Coinbase’s Crossroads — Bearish Signal Or Bullish Opportunity? Options Corner: Coinbase's Death Cross Dilemma - Coinbase Global (NASDAQ:COIN)